Related News:
- European Commission approves Roche’s Vabysmo, the…
- CHMP recommends EU conditional approval of Roche’s…
- New two-year data confirm Roche’s Vabysmo improves…
- Positive topline phase III results show Roche's…
- New phase III data show Roche’s Vabysmo rapidly…
- CHMP recommends EU approval of Roche’s Tecentriq as…